A drug manufacturer said that more than 11,000 bottles of prescription blood pressure medication are under recalls, according to a notice published this week on the Food and Drug Administration’s (FDA) website.
The notice said that chlorthalidone tablets, USP, in 25-milligram doses, are under recall for “failed dissolution specifications.” It added that 11,460 bottles are under recall, and the products have an April 2027 expiration date.
The recall impacts 100-count tablet bottles with the batch number, RISA24001, and 1,000-count tablet bottles with the batch number, RISB24002, it said.
The firm that made the medication, India-based Inventia Healthcare Limited, said the recall was initiated on June 5. The FDA, which hasn’t classified the recall yet, published the notice on its website this week, according to an Epoch Times review of its recall database….